Elevance Health (NYSE:ELV) Given Outperform Rating at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $478.00 price target on the stock. Several other research analysts have also recently weighed in on the company. Stephens cut Elevance Health from an “overweight” rating […]
Royal Bank of Canada restated their outperform rating on shares of Elevance Health (NYSE:ELV – Free Report) in a research note released on Wednesday,Benzinga reports. They currently have a $478.00 price target on the stock. Several other research analysts have also recently weighed in on the company. Stephens cut Elevance Health from an “overweight” rating […]
